NEW YORK, June 12 - Exelixis and RNA and RNA-interference company Dharmacon intend to develop a short-interfering RNA library for roughly 600 proprietary and publicly available genes.
NEW YORK, June 12 - Exelixis and RNA and RNA-interference company Dharmacon intend to develop a short-interfering RNA library for roughly 600 proprietary and publicly available genes.